Exchange: NASDAQ·Updated 07:30 PM EDT
SPRC logo

SPRC Scisparc Ltd

$4.47
$0.04
(0.90%)
Today
Closed $4.47
$0.00
(0.00%)
After Hours
Mkt Cap$2.56M
Vol4,818.00

About SPRC

SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. It operates through the Drug Development and Online Sales segments. The Drug Development segment focuses on cannabinoid molecules to be approved by an official regulatory authority. The Online Sales segment consists of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.
42

Bearish Sentiment

How do you feel about SPRC?

MrTicker
$SPRC SciSparc: Subsidiary NeuroThera Labs’ CliniQuantum Reports Successful Quantum-Enabled Analysis of Billions of Gene Combinations Using Real-World Clinical Data on an S&P 500 Company’s Quantum Architecture GLOBENEWSWIRE 7:22 AM ET 10/7/2026
MrTicker
$SPRC SciSparc: Subsidiary NeuroThera Labs’ CliniQuantum Reports Successful Quantum-Enabled Analysis of Billions of Gene Combinations Using Real-World Clinical Data on an S&P 500 Company’s Quantum Architecture GLOBENEWSWIRE 7:22 AM ET 10/7/2026
MrTicker
$SPRC looking good.. crossed $5.50 ... needs more volume to hit the scanner. Power hour around the corner.. $ARTL cooling off.. hit $15.73 HOD.. lets see if there is a reversal during power hour / after hours
focafoca99
$SPRC states its U.S. patent portfolio expands with three new applications covering LSD, ketamine and ibogaine combos.
Stock_Catcher
$SPRC SciSparc: Subsidiary NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with Clearmind Covering LSD, Ketamine and Ibogaine Combinations

Advertisement|Remove ads.